+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Enteric Softgel Capsules Market by Application, and Sales Channel: Global Opportunity Analysis and Industry Forecast, 2018 - 2025

  • ID: 4744565
  • Report
  • November 2018
  • Region: Global
  • 151 pages
  • Allied Analytics LLP
1 of 4
Enteric Softgel Capsules Market Overview:

The global enteric softgel capsules market generated $1,851 million in 2017, and is projected to reach $2,589 million by 2025, registering a CAGR of 4.2% from 2018 to 2025. Soft capsules are a single-unit solid dosage form, consisting of a liquid or semi-solid drug or extract within a soft shell. Enteric softgel capsules are a form of delayed release dosage forms, which protect either the drugs from the acidity of the stomach, or the stomach from the detrimental effects of the drug.

The global enteric softgel capsules market is expected to grow at a significant rate during the forecast period, owing to growth in number of R&D activities to increase bioavailability of the drug, surge in demand for softgel health supplements, rise in consumer awareness related to preventative healthcare, and proliferation of distribution channels. Further, improvement in lifestyle pattern, rise in geriatric population, and increase in number of self-directed consumers have fuelled the market growth. However, stability concern with some water-soluble compounds and high cost associated with softgel can impede the market growth.

The global enteric softgel capsules market is segmented based on application, sales channel, and region. Based on application, the market is classified as health supplements and pharmaceuticals. According to the sales channel, the market is segmented into supermarket & hypermarket, pharmacy & drug store, and online provider. Based on region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Key Benefits for Enteric Softgel Capsules Market:

The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2018 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
A comprehensive analysis of all the geographical regions is provided to determine the existing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

Enteric Softgel Capsules Key Market Segments:

By Application

Health Supplements
Pharmaceuticals

By Sales Channel

Supermarket & Hypermarket
Pharmacy & Drug Store
Online Provider

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

List Of Key Players Profiled in the Report

BASF SE,
Catalent, Inc.
Colorcon Inc.
Fuji Capsules Co. Ltd.
InovoBiologic Inc.
NOW Foods Inc.
Sirio Pharma Co., Ltd.
Super Spectrim
Thermo Fisher Scientific, Inc. (Patheon)
Trigen Laboratories, Inc.

List Of Other Players in the Value Chain (These players are not profiled in the report. The same will be included on request.)

Nature's Way Products, LLC.
Lonza Group Ltd
PROCAPS (softigel)
Note: Product cover images may vary from those shown
2 of 4
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.1.1. CXO perspective

Chapter 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top player positioning
3.3. MARKET DYNAMICS
3.3.1. Drivers
3.3.1.1. Surge in adoption of softgel capsules
3.3.1.2. Rapid growth of e-commerce
3.3.1.3. Surge in healthcare expenditure worldwide
3.3.2. Restraints
3.3.2.1. Poor demand in under developed countries
3.3.3. Opportunities
3.3.3.1. Growth opportunities in emerging markets
3.3.4. Impact analyses

Chapter 4: ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION
4.1. Overview
4.1.1. Market size and forecast
4.2. Health supplements
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.3. Pharmaceuticals
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country

Chapter 5: ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL
5.1. Overview
5.1.1. Market size and forecast
5.2. Supermarket & hypermarket
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Pharmacy & drug store
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.4. Online Provider
5.4.1. Market size and forecast
5.4.2. Market analysis, by country

Chapter 6: ENTERIC SOFTGEL CAPSULES MARKET BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by country
6.2.2.1. U.S.
6.2.2.1.1. U.S. enteric softgel capsules market, by application
6.2.2.1.2. U.S. enteric softgel capsules market, by sales channel
6.2.2.2. Canada
6.2.2.2.1. Canada enteric softgel capsules market, by application
6.2.2.2.2. Canada enteric softgel capsules market, by sales channel
6.2.2.3. Mexico
6.2.2.3.1. Mexico enteric softgel capsules market, by application
6.2.2.3.2. Mexico enteric softgel capsules market, by sales channel
6.2.3. North America enteric softgel capsules market, by application
6.2.4. North America enteric softgel capsules market, by sales channel
6.3. Europe
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by country
6.3.2.1. Germany
6.3.2.1.1. Germany enteric softgel capsules market, by application
6.3.2.1.2. Germany enteric softgel capsules market, by sales channel
6.3.2.2. France
6.3.2.2.1. France enteric softgel capsules market, by application
6.3.2.2.2. France enteric softgel capsules market, by sales channel
6.3.2.3. UK
6.3.2.3.1. UK enteric softgel capsules market, by application
6.3.2.3.2. UK enteric softgel capsules market, by sales channel
6.3.2.4. Italy
6.3.2.4.1. Italy enteric softgel capsules market, by application
6.3.2.4.2. Italy enteric softgel capsules market, by sales channel
6.3.2.5. Spain
6.3.2.5.1. Spain enteric softgel capsules market, by application
6.3.2.5.2. Spain enteric softgel capsules market, by sales channel
6.3.2.6. Rest of Europe
6.3.2.6.1. Rest of Europe enteric softgel capsules market, by application
6.3.2.6.2. Rest of Europe enteric softgel capsules market, by sales channel
6.3.3. Europe enteric softgel capsules market, by application
6.3.4. Europe enteric softgel capsules market, by sales channel
6.4. Asia-Pacific
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by country
6.4.2.1. Japan
6.4.2.1.1. Japan enteric softgel capsules market, by application
6.4.2.1.2. Japan enteric softgel capsules market, by sales channel
6.4.2.2. China
6.4.2.2.1. China enteric softgel capsules market, by application
6.4.2.2.2. China enteric softgel capsules market, by sales channel
6.4.2.3. Australia
6.4.2.3.1. Australia enteric softgel capsules market, by application
6.4.2.3.2. Australia enteric softgel capsules market, by sales channel
6.4.2.4. India
6.4.2.4.1. India enteric softgel capsules market, by application
6.4.2.4.2. India enteric softgel capsules market, by sales channel
6.4.2.5. South Korea
6.4.2.5.1. South Korea enteric softgel capsules market, by application
6.4.2.5.2. South Korea enteric softgel capsules market, by sales channel
6.4.2.6. Rest of Asia-Pacific
6.4.2.6.1. Rest of Asia-Pacific enteric softgel capsules market, by application
6.4.2.6.2. Rest of Asia-Pacific enteric softgel capsules market, by sales channel
6.4.3. Asia-Pacific enteric softgel capsules market, by application
6.4.4. Asia-Pacific enteric softgel capsules market, by sales channel
6.5. LAMEA
6.5.1. Key market trends, growth factors, and opportunities
6.5.2. Market size and forecast, by country
6.5.2.1. Brazil
6.5.2.1.1. Brazil enteric softgel capsules market, by application
6.5.2.1.2. Brazil enteric softgel capsules market, by sales channel
6.5.2.2. Saudi Arabia
6.5.2.2.1. Saudi Arabia enteric softgel capsules market, by application
6.5.2.2.2. Saudi Arabia enteric softgel capsules market, by sales channel
6.5.2.3. South Africa
6.5.2.3.1. South Africa enteric softgel capsules market, by application
6.5.2.3.2. South Africa enteric softgel capsules market, by sales channel
6.5.2.4. Rest of LAMEA
6.5.2.4.1. Rest of LAMEA enteric softgel capsules market, by application
6.5.2.4.2. Rest of LAMEA enteric softgel capsules market, by sales channel
6.5.3. LAMEA enteric softgel capsules market, by application
6.5.4. LAMEA enteric softgel capsules market, by sales channel
6.6. BASF SE
6.6.1. Company overview
6.6.2. Company snapshot
6.6.3. Operating business segments
6.6.4. Product Portfolio
6.6.5. Business performance
6.7. Catalent, Inc.
6.7.1. Company overview
6.7.2. Company snapshot
6.7.3. Operating business segments
6.7.4. Product Portfolio
6.7.5. Business performance
6.8. Colorcon, Inc.
6.8.1. Company overview
6.8.2. Company snapshot
6.8.3. Operating business segments
6.8.4. Product Portfolio
6.9. Fuji Capsules Co., Ltd.
6.9.1. Company overview
6.9.2. Company snapshot
6.9.3. Product Portfolio
6.10. Procaps
6.10.1. Company overview
6.10.2. Company snapshot
6.10.3. Operating business segments
6.10.4. Product Portfolio
6.11. NOW Foods Inc.
6.11.1. Company overview
6.11.2. Company snapshot
6.11.3. Operating business segments
6.11.4. Product Portfolio
6.12. Thermo Fisher Scientific, Inc. (Patheon)
6.12.1. Company overview
6.12.2. Company snapshot
6.12.3. Operating business segments
6.12.4. Product Portfolio
6.12.5. Business performance
6.12.6. Key strategic moves and developments
6.13. Sirio Pharma Co., LTD
6.13.1. Company overview
6.13.2. Company snapshot
6.13.3. Operating business segments
6.13.4. Product Portfolio
6.14. Super Spectrim
6.14.1. Company overview
6.14.2. Company snapshot
6.14.3. Operating business segments
6.14.4. Product Portfolio
6.15. Trigen Laboratories, Inc.
6.15.1. Company overview
6.15.2. Company snapshot
6.15.3. Operating business segments
6.15.4. Product Portfolio

List Of Tables
Table 01. Global Enteric Softgel Capsules Market, By Application, 2017-2025 ($Million)
Table 02. Health Supplements Enteric Softgel Capsules Market, By Region, 2017-2025 ($Million)
Table 03. Pharmaceuticals Enteric Softgel Capsules Market, By Region, 2017-2025 ($Million)
Table 04. Global Enteric Softgel Capsules Market, By Sales Channel, 2017-2025 ($Million)
Table 05. Supermarkets & Hypermarkets Enteric Softgel Capsules Market, By Region, 2017-2025 ($Million)
Table 06. Pharmacy & Drug Store Enteric Softgel Capsules Market, By Region, 2017-2025 ($Million)
Table 07. Online Providers Enteric Softgel Capsules Market, By Region, 2017-2025 ($Million)
Table 08. Enteric Softgel Capsules Market, By Region, 2017-2025 ($Million)
Table 09. North America Enteric Softgel Capsules Market, By Country, 2017-2025 ($Million)
Table 10. U.S. Enteric Softgel Capsules Market, By Application, 2017-2025 ($Million)
Table 11. U.S. Enteric Softgel Capsules Market, By Sales Channel, 2017-2025 ($Million)
Table 12. Canada Enteric Softgel Capsules Market, By Application, 2017-2025 ($Million)
Table 13. Canada Enteric Softgel Capsules Market, By Sales Channel, 2017-2025 ($Million)
Table 14. Mexico Enteric Softgel Capsules Market, By Application, 2017-2025 ($Million)
Table 15. Mexico Enteric Softgel Capsules Market, By Sales Channel, 2017-2025 ($Million)
Table 16. North America Enteric Softgel Capsules Market, By Application, 2017-2025 ($Million)
Table 17. North America Enteric Softgel Capsules Market, By Sales Channel, 2017-2025 ($Million)
Table 18. Europe Enteric Softgel Capsules Market, By Country, 2017-2025 ($Million)
Table 19. Germany Enteric Softgel Capsules Market, By Application, 2017-2025 ($Million)
Table 20. Germany Enteric Softgel Capsules Market, By Sales Channel, 2017-2025 ($Million)
Table 21. France Enteric Softgel Capsules Market, By Application, 2017-2025 ($Million)
Table 22. France Enteric Softgel Capsules Market, By Sales Channel, 2017-2025 ($Million)
Table 23. UK Enteric Softgel Capsules Market, By Application, 2017-2025 ($Million)
Table 24. UK Enteric Softgel Capsules Market, By Sales Channel, 2017-2025 ($Million)
Table 25. Italy Enteric Softgel Capsules Market, By Application, 2017-2025 ($Million)
Table 26. Italy Enteric Softgel Capsules Market, By Sales Channel, 2017-2025 ($Million)
Table 27. Spain Enteric Softgel Capsules Market, By Application, 2017-2025 ($Million)
Table 28. Spain Enteric Softgel Capsules Market, By Sales Channel, 2017-2025 ($Million)
Table 29. Rest Of Europe Enteric Softgel Capsules Market, By Application, 2017-2025 ($Million)
Table 30. Rest Of Europe Enteric Softgel Capsules Market, By Sales Channel, 2017-2025 ($Million)
Table 31. Europe Enteric Softgel Capsules Market, By Application, 2017-2025 ($Million)
Table 32. Europe Enteric Softgel Capsules Market, By Sales Channel, 2017-2025 ($Million)
Table 33. Asia- Pacific Enteric Softgel Capsules Market, By Country, 2017-2025 ($Million)
Table 34. Japan Enteric Softgel Capsules Market, By Application, 2017-2025 ($Million)
Table 35. Japan Enteric Softgel Capsules Market, By Sales Channel, 2017-2025 ($Million)
Table 36. China Enteric Softgel Capsules Market, By Application, 2017-2025 ($Million)
Table 37. China Enteric Softgel Capsules Market, By Sales Channel, 2017-2025 ($Million)
Table 38. Australia Enteric Softgel Capsules Market, By Application, 2017-2025 ($Million)
Table 39. Australia Enteric Softgel Capsules Market, By Sales Channel, 2017-2025 ($Million)
Table 40. India Enteric Softgel Capsules Market, By Application, 2017-2025 ($Million)
Table 41. India Enteric Softgel Capsules Market, By Sales Channel, 2017-2025 ($Million)
Table 42. South Korea Enteric Softgel Capsules Market, By Application, 2017-2025 ($Million)
Table 43. South Korea Enteric Softgel Capsules Market, By Sales Channel, 2017-2025 ($Million)
Table 44. Rest Of Asia-Pacific Enteric Softgel Capsules Market, By Application, 2017-2025 ($Million)
Table 45. Rest Of Asia-Pacific Enteric Softgel Capsules Market, By Sales Channel, 2017-2025 ($Million)
Table 46. Asia-Pacific Enteric Softgel Capsules Market, By Application, 2017-2025 ($Million)
Table 47. Asia-Pacific Enteric Softgel Capsules Market, By Sales Channel, 2017-2025 ($Million)
Table 48. LAMEA Enteric Softgel Capsules Market, By Country, 2017-2025 ($Million)
Table 49. Brazil Enteric Softgel Capsules Market, By Application, 2017-2025 ($Million)
Table 50. Brazil Enteric Softgel Capsules Market, By Sales Channel, 2017-2025 ($Million)
Table 51. Saudi Arabia Enteric Softgel Capsules Market, By Application, 2017-2025 ($Million)
Table 52. Saudi Arabia Enteric Softgel Capsules Market, By Sales Channel, 2017-2025 ($Million)
Table 53. South Africa Enteric Softgel Capsules Market, By Application, 2017-2025 ($Million)
Table 54. South Africa Enteric Softgel Capsules Market, By Sales Channel, 2017-2025 ($Million)
Table 55. Rest Of LAMEA Enteric Softgel Capsules Market, By Application, 2017-2025 ($Million)
Table 56. Rest Of LAMEA Enteric Softgel Capsules Market, By Sales Channel, 2017-2025 ($Million)
Table 57. LAMEA Enteric Softgel Capsules Market, By Application, 2017-2025 ($Million)
Table 58. LAMEA Enteric Softgel Capsules Market, By Sales Channel, 2017-2025 ($Million)
Table 59. Basf Se: Company Snapshot
Table 60. Basf Se: Operating Segments
Table 61. Basf Se: Product Portfolio
Table 62. Catalent, Inc.: Company Snapshot
Table 63. Catalent, Inc: Operating Segments
Table 64. Catalent, Inc.: Product Portfolio
Table 65. Colorcon, Inc.: Company Snapshot
Table 66. Colorcon, Inc.: Operating Segments
Table 67. Colorcon, Inc.: Product Portfolio
Table 68. Fuji Capsules Co., Ltd.: Company Snapshot
Table 69. Fuji Capsules Co., Ltd.: Product Portfolio
Table 70. Procaps.: Company Snapshot
Table 71. Procaps.: Operating Segments
Table 72. Procaps.: Product Portfolio
Table 73. Now Foods: Company Snapshot
Table 74. Now Foods: Operating Segments
Table 75. Now Foods: Product Portfolio
Table 76. Thermo Fisher Scientific: Company Snapshot
Table 77. Thermo Fisher Scientific: Operating Segments
Table 78. Thermo Fisher Scientific: Product Portfolio
Table 79. Sirio Pharma Co., Ltd.: Company Snapshot
Table 80. Sirio Pharma Co., Ltd.: Operating Segments
Table 81. Sirio Pharma Co., Ltd.: Product Portfolio
Table 82. Super Spectrim.: Company Snapshot
Table 83. Super Spectrim: Operating Segments
Table 84. Super Spectrim: Product Portfolio
Table 85. Trigen Laboratories, Inc..: Company Snapshot
Table 86. Trigen Laboratories, Inc.: Operating Segments
Table 87. Trigen Laboratories, Inc.: Product Portfolio

List of Figures
Figure 01. Enteric Softgel Capsules Market Segmentation
Figure 02. Top Investment Pockets In The Global Enteric Softgel Capsules Market
Figure 03. Top Player Positioning, 2017
Figure 04. Impact Analyses
Figure 05. Comparative Analysis Of Health Supplements Enteric Softgel Capsules Market, By Country, 2017 & 2025 ($Million)
Figure 06. Comparative Analysis Of Pharmaceuticals Enteric Softgel Capsules Market, By Country, 2017 & 2025 ($Million)
Figure 07. Comparative Analysis Of Supermarket & Hypermarket Enteric Softgel Capsules Market, By Country, 2017 & 2025 ($Million)
Figure 08. Comparative Analysis Of Pharmacy & Drug Store Enteric Softgel Capsules Market, By Country, 2017 & 2025 ($Million)
Figure 09. Comparative Analysis Of Online Provider Enteric Softgel Capsules Market, By Country, 2017 & 2025 ($Million)
Figure 10. Basf Se: Revenue, 2015-2017 ($Million)
Figure 11. Basf Se: Revenue Share By Business Segment, 2017 (%)
Figure 12. Basf Se: Revenue Share By Geographic Segment, 2017 (%)
Figure 13. Catalent, Inc.: Revenue, 2015-2017 ($Million)
Figure 14. Catalent, Inc.: Revenue Share By Business Segment, 2017 (%)
Figure 15. Catalent, Inc: Revenue Share By Geographic Segment, 2017 (%)
Figure 16. Thermo Fisher Scientific: Revenue, 2015-2017 ($Million)
Figure 17. Thermo Fisher Scientific: Revenue Share By Segments, 2017 (%)
Figure 18. Thermo Fisher Scientific: Revenue Share By Geography, 2017 (%)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
According to this report titled, 'Enteric Softgel Capsules Market, by Application and Sales Channel: Global Opportunity Analysis and Industry Forecast, 2018-2025', the global enteric softgel capsules market was valued at $1,851 million in 2017, and is expected to reach $2,589 million by 2025, growing at a CAGR of 4.2% from 2018 to 2025.

A softgel capsules are hermetically sealed solid dosage forms, containing liquid or semi-solid center active ingredient or the extract incorporated into the outer shell. Growth in number of self-directed consumers, surge in consumer awareness related to preventative healthcare, increase in adoption of health supplements, and rise in adoption of enteric softgel capsules in the emerging economies are key drivers of the enteric softgel capsules market.

Based on application, the enteric softgel capsules market is segmented as health supplements, and pharmaceuticals. At present, the health supplements segment dominates the global market, and is anticipated to continue this trend during the forecast period. This is attributed to its high adoption, growth in awareness for preventative healthcare, and increase in usage of omega-3 supplements in emerging economies.

Based on sales channel, the global enteric softgel capsules market is segmented into supermarket & hypermarket, pharmacy & drug store, and online provider. At present, the pharmacy & drug store segment is the major revenue contributor and is projected to remain dominant during the forecast period. Whereas, the online provider segment is expected to exhibit rapid growth in the market during the forecast period, due to rise in number of internet users and increase in awareness about online pharmacy.

Key Findings of the Enteric Softgel Capsules Market:

Based on application, the health supplements segment is expected to experience rapid growth in the market and is projected to grow at a CAGR of 4.3% from 2018 to 2025.
Based on sales channel, the pharmacy & drug store segment held more than half of the global market share in 2017 and is expected to remain dominant throughout the forecast period.
Based on region, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 5.5% during the forecast period.

North America accounted for approximately half the global market share in 2017 and is expected to remain dominant throughout the forecast period. This was attributed to the higher demand for enteric softgel capsules, rise in number of self-directed consumers, and supportive reimbursement policies in the healthcare system. However, Asia-Pacific is expected to experience the highest growth rate during the forecast period majorly due to, rise in adoption of enteric coated health supplements softgel, surge in healthcare awareness, and increase in number of R&D activities.
Note: Product cover images may vary from those shown
5 of 4

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Adroll
adroll